Satius v. Samsung: a claim reciting an impossible alternative is definite, but the Federal Circuit holds it invalid for lack of enablement under Amgen.
Continue reading this post on Patently-O.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Pre-Suit Validity Investigation: When Must a Patentee Look Before Suing? | 0 | 13.47 | 05-10-2026 |
| 2 | Method or Molecule: Judge Dyk Dissents from En Banc Denial in Teva v. Lilly | 0 | 8.62 | 01-10-2026 |
| 3 | Recent Changes in Discretionary Denials of Drug Patent Challenges | 0 | 8.63 | 09-09-2026 |
| 4 | One Determination, Two Clocks: Crocs Asks the Supreme Court to Fix ITC Appeal Deadlines | 0 | 7.01 | 29-09-2026 |
| 5 | FY2026 Patent Data Update: Grants, Publications, and Cross-Border Inventors | 0 | 25.46 | 02-10-2026 |
| 6 | Parting Shot: Mandamus Sends USC v. Google from Judge Albright’s Austin Docket to N.D. Cal. | 0 | 7.13 | 07-10-2026 |
| 7 | Tie Goes to the Applicant: The USPTO’s SMED Flowchart | 0 | 8.87 | 29-09-2026 |
| 8 | Ease Is Not Necessity: Third Circuit Affirms No Fair Use in Thomson Reuters v. ROSS | 0 | 7.07 | 01-10-2026 |
| 9 | PTAB Invalidates Challenged Claims In Breast Pump Patent | 0 | 6.32 | 25-09-2026 |
| 10 | Medivis Gets Some AR Device Patent Claims Cut In Remand | 0 | 5.63 | 02-10-2026 |